Portfolio company
Mimetic Medicines
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Latigo Biotherapeutics
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.
Latigo
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.
Synerkine Pharma
This company develops fusion protein therapeutics to treat chronic pain and peripheral neuropathy for patients with inflammatory and neurodegenerative conditions.
PainReform
This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.
Meddenovo
This company develops an artificial intelligence platform for de novo cyclic peptide drug discovery to support pharmaceutical and biotechnology firms.
Aizen Therapeutics
This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
Nervonik
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems for patients suffering from chronic neuropathic pain.
